Scaffold-hopping

InhibOx announces LOx - a new system for versatile fragment-based design

Submitted by InhibOx on 28 October 2010 - 9:30am

LOx offers a new pharmacophoric linking approach, integrated with Scopius, the largest available curated 3D compound and fragment database

Oxford, UK, October 28th, 2010. InhibOx Ltd today announces LOx 2.0 - a flexible new system to identify and optimize drug lead candidates through preserving and linking critical features with new scaffolds. Lox 2.0 carries fragment-linking tools a stage further and delivers a powerful approach for drug discovery scientists seeking to alter the core scaffold of a lead series to maximize activity, optimize physical properties and to create novel intellectual property.

InhibOx Announces Important Breakthrough in Molecular Similarity: Chiral Shape Recognition (CSR)

Submitted by InhibOx on 15 November 2009 - 4:00pm

Oxford, UK - November 2009

The quantitative measurement of molecular similarity has long been an essential tool in computer-aided drug discovery, in particular for the identification of new leads and scaffold hopping. Until now, however, there has been no fast, non-superpositional method that accounts for enantiomeric (mirror image) molecules, an essential facet of many biological interactions. InhibOx has now made an important breakthrough to meet this challenge.